Investing.com - Financial Markets Worldwide
Open in App

TransGenic Group Inc (2342)

Tokyo
Currency in JPY
244.0
-7.0(-2.79%)
Closed·

2342 Income Statement

Period Ending:
2017
31/03
2018
31/03
2019
31/03
2020
31/03
2021
31/03
2022
31/03
2023
31/03
2024
31/03
2025
31/03
2026
31/03
Total Revenues
aa.aaaa.aaaa.aaaa.aaaa.aa12,57611,42913,08313,00513,174
Total Revenues Growth
aa.aaaa.aaaa.aaaa.aaaa.aa+13.85%-9.12%+14.47%-0.6%+1.3%
Cost Of Revenues
aa.aaaa.aaaa.aaaa.aaaa.aa8,7419,43510,83510,83810,741
Gross Profit
aa.aaaa.aaaa.aaaa.aaaa.aa3,8351,9942,2482,1672,433
Gross Profit Growth
aa.aaaa.aaaa.aaaa.aaaa.aa+38.1%-48.01%+12.74%-3.6%+12.28%
Gross Profit Margin %
aa.aaaa.aaaa.aaaa.aaaa.aa30.49%17.45%17.18%16.66%18.47%
Other Operating Expenses, Total
aa.aaaa.aaaa.aaaa.aaaa.aa1,9982,0192,1462,4222,295
Other Operating Expenses, Total Growth
R&D Expenses
Selling General & Admin Expenses
Other Operating Expenses
Operating Income
aa.aaaa.aaaa.aaaa.aaaa.aa1,837-25102-255138
Operating Income Growth
aa.aaaa.aaaa.aaaa.aaaa.aa+105.02%-101.36%+508%-350%+154.12%
EBIT Margin %
aa.aaaa.aaaa.aaaa.aaaa.aa14.61%-0.22%0.78%-1.96%1.05%
Net Interest Expenses
aa.aaaa.aaaa.aaaa.aaaa.aa-22-28-47-36-41
Net Interest Expenses Growth
aa.aaaa.aaaa.aaaa.aaaa.aa+15.38%-27.27%-67.86%+23.4%-13.89%
Interest Expense, Total
aa.aaaa.aaaa.aaaa.aaaa.aa-22-28-47-37-45
Interest And Investment Income
aa.aaaa.aaaa.aaaa.aaaa.aa---14
Other Non Operating Expenses, Total
aa.aaaa.aaaa.aaaa.aaaa.aa325353-2823
EBT, Excl. Unusual Items
aa.aaaa.aaaa.aaaa.aaaa.aa1,818200108-319120
Gain (Loss) On Sale Of Assets
aa.aaaa.aaaa.aaaa.aaaa.aa-34-31-
Other Unusual Items, Total
aa.aaaa.aaaa.aaaa.aaaa.aa-394-552-62-347-463
EBT, Incl. Unusual Items
aa.aaaa.aaaa.aaaa.aaaa.aa2,767-33143-675-206
EBT, Incl. Unusual Items Growth
aa.aaaa.aaaa.aaaa.aaaa.aa+298.13%-111.96%+112.99%-1,669.77%+69.48%
EBT, Incl. Unusual Items Margin
aa.aaaa.aaaa.aaaa.aaaa.aa22%-2.9%0.33%-5.19%-1.56%
Income Tax Expense
aa.aaaa.aaaa.aaaa.aaaa.aa90710839414-109
Net Income to Company
aa.aaaa.aaaa.aaaa.aaaa.aa1,860-4394-1,089-97
Minority Interest
aa.aaaa.aaaa.aaaa.aaaa.aa1630--20
Net Income
aa.aaaa.aaaa.aaaa.aaaa.aa1,876-4094-1,089-77
Net Income Growth
aa.aaaa.aaaa.aaaa.aaaa.aa+243.59%-121.8%+100.98%-27,325%+92.93%
Net Income Margin %
aa.aaaa.aaaa.aaaa.aaaa.aa14.92%-3.58%0.03%-8.37%-0.58%
Preferred Dividend and Other Adjustments
aa.aaaa.aaaa.aaaa.aaaa.aa-----
Net Income to Common Excl. Extra Items
aa.aaaa.aaaa.aaaa.aaaa.aa1,876-4094-1,089-77
Basic EPS - Continuing Operations
aa.aaaa.aaaa.aaaa.aaaa.aa109.5-24.280.24-65.47-4.62
Basic EPS - Continuing Operations Growth
aa.aaaa.aaaa.aaaa.aaaa.aa+248.31%-122.18%+100.98%-27,600.87%+92.94%
Diluted EPS - Continuing Operations
aa.aaaa.aaaa.aaaa.aaaa.aa109.31-24.280.24-65.47-4.62
Diluted EPS - Continuing Operations Growth
aa.aaaa.aaaa.aaaa.aaaa.aa+247.7%-122.21%+100.98%-27,600.87%+92.94%
Basic Weighted Average Shares Outstanding
aa.aaaa.aaaa.aaaa.aaaa.aa17.1316.8416.816.6316.65
Diluted Weighted Average Shares Outstanding
aa.aaaa.aaaa.aaaa.aaaa.aa17.1616.8416.816.6316.65
Dividend Per Share
aa.aaaa.aaaa.aaaa.aaaa.aa333--
Dividend Per Share Growth
aa.aaaa.aaaa.aaaa.aaaa.aa0%0%0%--
EBITDA
aa.aaaa.aaaa.aaaa.aaaa.aa2,064157251-14293
EBITDA Growth
aa.aaaa.aaaa.aaaa.aaaa.aa+79.95%-92.39%+59.87%-105.58%+2,192.86%
EBITDA Margin %
aa.aaaa.aaaa.aaaa.aaaa.aa16.41%1.37%1.92%-0.11%2.22%
EBIT
aa.aaaa.aaaa.aaaa.aaaa.aa1,837-25102-255138
* In Millions of JPY (except for per share items)

FAQ

What was TransGenic Group’s revenue at year end?

At the end of the last reported fiscal year, TransGenic Group (2342) recorded total revenue of 13,174.0 million JPY.

How much revenue did TransGenic Group report in the most recent quarter?

In its most recent quarterly earnings report, TransGenic Group posted revenue of 3,659.0 million JPY.

What was TransGenic Group’s net income for the year?

For the full year, TransGenic Group reported net income of -77.0 million JPY.

How much net income did TransGenic Group post in the last quarter?

In the most recent quarter, TransGenic Group (2342) posted net income of 136.0 million JPY.

What was TransGenic Group’s gross profit for the year?

Gross profit for the year was reported at 2,433.0 million JPY.

How much gross profit did TransGenic Group generate last quarter?

TransGenic Group recorded gross profit of 715.0 million JPY in its latest quarterly report.

What was TransGenic Group’s annual operating income?

For the full year, TransGenic Group (2342) reported operating income of 138.0 million JPY.

What was TransGenic Group’s operating income last quarter?

Quarterly operating income was 164.0 million JPY.

What was TransGenic Group’s quarterly EBITDA?

In the latest quarter, EBITDA was reported at 202.8 million JPY.

What was the quarter-over-quarter change in EBITDA for TransGenic Group?

EBITDA changed by 182.6% million JPY compared to the last quarter.

What is TransGenic Group’s most recent gross profit margin?

The latest reported gross profit margin for TransGenic Group (2342) is 19.5% million JPY.

What is TransGenic Group’s most recent net income margin?

Net income margin based on recent financials is 3.7% million JPY.

What is TransGenic Group’s most recent EBIT margin?

TransGenic Group reported an EBIT margin of 4.5% million JPY based on current figures.

How did TransGenic Group’s revenue change compared to the previous quarter?

Revenue changed by 5.2% million JPY compared to the prior quarter.

What was the quarter-over-quarter change in gross profit for TransGenic Group?

In the latest quarter, gross profit changed by 20.2% million JPY from the previous quarter.
Install Our App
Follow us
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.